Bringing the fundamentals into focus…
Back to Travere Therapeutics, Inc.
How Travere Therapeutics, Inc. stacks up
TVTX · against 224 other Healthcare companies of similar size
Growth
95/ 100
Near the top of its peers.
Ranked #16 of 225 · scores higher than 92% of peers
Bars: peers in each 10-point band of the growth score34 peers with a growth score of 90–100, including TVTX · Click a bar to see the companies
Why growth scores 95?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over the last year: stronger than 93% of peers. Revenue growth: 77.1% vs peer median 6.1%
- faster revenue growth over three years: stronger than 96% of peers. 3-year revenue growth: 103.8% vs peer median 5.8%
Metric by metric
Position: dot = TVTX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | TVTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 224 reported | 77.1% | 8.9% | 92% | 33% | |
| Earnings per share growthHigher is better · 143 reported | Not reported | 9.8% | — | — | 33% |
| 3-year revenue growthHigher is better · 217 reported | 103.8% | 9.0% | 94% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around TVTX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 2.8B USD | 99 | 51 | |
| 2 | 15.6B DKK (≈$2.3B) | 99 | 96 | |
| 14 | 5.7B USD | 96 | 52 | |
| 14 | 3.4B USD | 96 | 48 | |
| 16 | 9.0B USD | 95 | 51 | |
| 16 | 3.0B USD | 95 | 54 | |
| 16 | 4.7B USD | 95 | 42 | |
| 19 | 71.0B HKD (≈$9.1B) | 94 | 54 | |
| 20 | 22.1B CNY (≈$3.1B) | 93 | 49 | |
| 20 | 4.2B USD | 93 | 44 | |
| 20 | 9.2B USD | 93 | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score